GenesysCapital_Logo
  • About
  • Team
  • Portfolio
  • News
  • LP Login
LP Login
Left arrow Icon
Back to News

Flosonics Medical Secures $7.5 Million CAD Venture Debt from RBCx to Scale Transformative Wearable Ultrasound Technology

03 Mar 2025

Canadian medical device innovator, Flosonics Medical, has secured $7.5 million CAD in venture debt financing from RBCx.

View Full Article

Latest

Antegrade Medical Announces the Closing of a $7.3M Seed Financing

28 October 2025

World’s First Wearable Doppler Ultrasound Patch Expands to East Coast to Enhance Patient Safety at The Mount Sinai Hospital

17 June 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

27 May 2025

All Articles

October 28, 2025

Antegrade Medical Announces the Closing of a $7.3M Seed Financing

Read More
June 17, 2025

World’s First Wearable Doppler Ultrasound Patch Expands to East Coast to Enhance Patient Safety at The Mount Sinai Hospital

Read More
June 11, 2025

Genesys Capital is closing its largest fund to date – Genesys Ventures IV LP

Read More
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Read More
See All
About
Team
Portfolio
News
Contact
GenesysCapital_Logo
123 Front Street West, Suite 1503
Toronto ON M5J 2M2
info@genesyscapital.com
Follow us on LinkedIn
Privacy Policy
© 2025 Genesys Capital. All rights reserved.